About 200 reports

  • MARKET ECOSYSTEM
  • MARKET DRIVERS

Every ## minutes, one person is added to the organ transplant wait list.

  • Transplantation
  • World
  • Baxter International Inc.
  • BioLife Solutions, Inc.
  • CryoLife, Inc.
  • EUROPE SKIN GRAFT REVENUE MARKET REVENUE OVERVIEW, BY COUNTRY, 2017 (US$ MN)
  • 12. NORTH AMERICA SKIN GRAFT MARKET REVENUE AND FORECASTS TO 2025

TABLE ##.

  • Transplantation
  • World
  • Forecast
  • Market Size
  • Avita Medical Ltd.
  • GROWTH OPPORTUNITIES IN THE TRANSPLANTABLE ORGAN PRESERVATION AND
  • 4.4 TRANSPLANTABLE ORGAN PRESERVATION AND TRANSPORT

K. ) E-## (U. K. , S PAIN, ITAL Y & G ERMAN Y) ##. ##. ## ##. ##. ##. ## ##. ##. ##. ## T r a n s p l a n t s c a n d a l i n G e r m a n y TABLE ## In 2012, a scandal over organ transplants sparked a debate on medical ethics in Germany.

  • Transplantation
  • North America
  • United States
  • Market Size
  • TransMedics, Inc.
  • Transplant Type
  • Transplant Type

FIGURE ## ## ##. ##. ## U S FIGURE ## The US is expected to dominate the transplant diagnostics market in North America with a share of ##. ##% in 2018.

  • Genome Sequencing
  • Transplantation
  • North America
  • United States
  • Market Size

Organ and Tissue Transplantation and Alternatives Chapter- ##: Introduction - Complimentary ## REASONS FOR DOING THE STUDY STUDY GOALS AND OBJECTIVES SCOPE OF REPORT METHODOLOGIES AND INFORMATION SOURCES ANALYST' S CREDENTIALS RELATED BCC RESEARCH REPORTS BCC RESEARCH WEBSITE DI

  • General Medicine And Specialty Medicine
  • Transplantation
  • World

Most of the people are given platelet concentrate to prevent bleeding during treatment with chemotherapy or stem cell transplant.

  • Transplantation
  • United States
  • Medtronic, Inc.
  • NuVasive, Inc.
  • Stryker Corporation
  • Heart Transplant Rejection - Overview
  • Heart Transplant Rejection - Dormant Projects

Heart transplant replaces an injured or diseased heart with a healthy one.

  • Heart Transplant
  • Medical Biotechnology
  • Pharmaceutical
  • Transplantation
  • Astellas Pharma Inc.
  • Lung Transplant Rejection - Overview
  • Lung Transplant Rejection - Dormant Projects

Transplant rejection is one of the key challenges of organ transplantation.

  • Lung Transplant
  • Therapy
  • Transplantation
  • United States
  • Kamada Ltd.
  • TOP COMPANIES PARTICIPATING IN BONE MARROW TRANSPLANT REJECTION THERAPEUTICS CLINICAL TRIALS
  • BONE MARROW TRANSPLANT REJECTION THERAPEUTICS, GLOBAL, CLINICAL TRIALS BY PHASE (%), 2018*

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## Johnson & Johnson ## ## ## ## ## ## ## ## Astellas Pharma Inc ## ## ## ## ## ## ## ## Takeda Pharmaceutical Co Ltd ## ## ## ## ## ## ## ## Incyte Corp ## ## ## ## ## ## ## ## Bellicum Pharmaceuticals Inc ## ##

  • Monoclonal Antibody
  • Pharmaceutical
  • Transplantation
  • United States
  • World
  • Liver Transplant Rejection - Overview
  • Liver Transplant Rejection - Discontinued Products

Liver transplant replaces an injured or diseased liver with a healthy one.

  • General Medicine And Specialty Medicine
  • Therapy
  • Transplantation
  • United States
  • Product Initiative
  • TOP COMPANIES PARTICIPATING IN STEM CELL TRANSPLANTATION THERAPEUTICS CLINICAL TRIALS
  • Sanofi have conducted highest number of stem cell transplantation clinical trials.

CLINICAL TRIALS BY PHASE IN G## COUNTRIES STEM CELL TRANSPLANTATION THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* STEM CELL TRANSPLANTATION THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* STEM CELL TRANSPLANTATION THERAPEUTICS, G## COUNTRIES, CLINIC

  • Drug Development
  • General Medicine And Specialty Medicine
  • Transplantation
  • World
  • Product Initiative
  • tacrolimus alone or in combination has the highest number of kidney transplant rejection ongoing clinical trials.
  • Clinical Trial profile. 137 Trial Title

CLINICAL TRIALS BY PHASE IN E## COUNTRIES KIDNEY TRANSPLANT REJECTION THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* KIDNEY TRANSPLANT REJECTION THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* KIDNEY TRANSPLANT REJECTION THERAPEUTICS, E## COUNTRIES,

  • Clinical Trial
  • Immunology
  • Monoclonal Antibody
  • Transplantation
  • Novartis AG
  • 2.1 Asia & Middle East Kidney Transplant Number & Forecast
  • 4.2.1 Hong Kong Kidney Transplant Number & Forecast

THE KIDNEY TRANSPLANT SUCCESS RATE IN ISRAEL IS ONE OF THE HIGHEST IN THE WORLD.

  • Transplantation
  • Asia
  • East Asia
  • Middle East
  • Forecast

By solution, the market is categorized into custodiol htk – (histidine-tryptophan-ketoglutarate) solution, human biosystem (hbs) solution, hypothermosol, lifor, perfadex, renograf, sirna transplant solution, university of wisconsin solution (uw solution), viaspan and other preservation solu

  • General Medicine And Specialty Medicine
  • Transplantation
  • United States
  • Forecast
  • LATEST CLINICAL TRIALS NEWS ON LUNG TRANSPLANT REJECTION
  • LUNG TRANSPLANT REJECTION THERAPEUTICS, E7 COUNTRIES, CLINICAL TRIALS BY PHASE, 2017*

CLINICAL TRIALS BY PHASE IN G## COUNTRIES LUNG TRANSPLANT REJECTION THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* LUNG TRANSPLANT REJECTION THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* LUNG TRANSPLANT REJECTION THERAPEUTICS, G## COUNTRIES, CLINIC

  • Clinical Trial
  • Lung Transplant
  • Monoclonal Antibody
  • Transplantation
  • Novartis AG
  • LIVER TRANSPLANT REJECTION THERAPEUTICS, E7 COUNTRIES, CLINICAL TRIALS BY PHASE, 2017*
  • LIVER TRANSPLANT REJECTION THERAPEUTICS, GLOBAL, CLINICAL TRIALS BY PHASE (%), 2017*

CLINICAL TRIALS BY PHASE IN E## COUNTRIES LIVER TRANSPLANT REJECTION THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* LIVER TRANSPLANT REJECTION THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* LIVER TRANSPLANT REJECTION THERAPEUTICS, E## COUNTRIES, CLI

  • Clinical Trial
  • Liver Transplant
  • Therapy
  • Transplantation
  • Novartis AG
  • Heart Transplant Rejection - Overview
  • Heart Transplant Rejection - Dormant Projects

Heart transplant replaces an injured or diseased heart with a healthy one.

  • Medical Biotechnology
  • Therapy
  • Transplantation
  • World
  • Product Initiative
  • HEART TRANSPLANT REJECTION THERAPEUTICS, GLOBAL, CLINICAL TRIALS BY PHASE (%), 2017*
  • HEART TRANSPLANT REJECTION THERAPEUTICS, G7 COUNTRIES, CLINICAL TRIALS BY TRIAL STATUS, 2017*

HEART TRANSPLANT REJECTION THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT STATUS, 2017* CLINICAL TRIALS BY END POINT STATUS HEART TRANSPLANT REJECTION THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT STATUS, 2017* HEART TRANSPLANT REJECTION THERAPEUTICS CLINICAL TRIA

  • Clinical Trial
  • Heart Transplant
  • Pharmaceutical
  • Transplantation
  • Novartis AG
  • PRODUCT PROFILE - VOCLOSPORIN
  • COMMERCIAL POSITIONING

TRANSPLANTATION; ##(##): ##-##.

  • Transplantation
  • World
  • Market Size
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Lung Transplant Rejection - Overview
  • Lung Transplant Rejection - Therapeutics Assessment

Transplant rejection is one of the key challenges of organ transplantation.

  • General Medicine And Specialty Medicine
  • Lung Transplant
  • Therapy
  • Transplantation
  • United States
  • BALMES TRANSPLANTATION SAS
  • KIDNEY TRANSPLANT REJECTION - PIPELINE BY BALMES TRANSPLANTATION SAS, H2 2018

TRANSPLANT REJECTION IS ONE OF THE KEY CHALLENGES OF ORGAN TRANSPLANTATION.

  • Health Services
  • Therapy
  • Transplantation
  • United States
  • Product Initiative
  • Bone Marrow Transplant Rejection - Discontinued Products
  • Bone Marrow Transplant Rejection - Product Development Milestones

Similarly, the Universities portfolio in Phase III, Phase I, Preclinical and Discovery stages comprises ##, ##, ## and ## molecules, respectively.

  • Health Services
  • Pharmaceutical
  • Specialty Hospital
  • Therapy
  • Transplantation
  • Liver Transplant Rejection - Overview
  • Liver Transplant Rejection - Discontinued Products

Liver transplant replaces an injured or diseased liver with a healthy one.

  • Digestive System Disorder
  • General Medicine And Specialty Medicine
  • Transplantation
  • United States
  • Product Initiative
  • BONE MARROW TRANSPLANT REJECTION THERAPEUTICS, GLOBAL, CLINICAL TRIALS BY REGION (%), 2017*
  • PROPORTION OF BONE MARROW TRANSPLANT REJECTION TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2017*

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## Takeda Pharmaceutical Company Ltd ## ## ## ## ## ## ## ## Pfizer Inc ## ## ## ## ## ## ## ## Neopharm Ltd ## ## ## ## ## ## ## ## Mallinckrodt Plc ## ## ## ## ## ## ## ## Bellicum Pharmaceutic

  • Clinical Trial
  • Drug Development
  • Pharmaceutical
  • Transplantation
  • World

ReNeuron Group Plc (UK) ##.

  • Transplantation
  • Europe
  • United States
  • World
  • Market Shares
  • Bone Marrow Transplant Rejection - Overview
  • Bone Marrow Transplant Rejection - Product Development Milestones

Significant survival advantages for the abatacept group were demonstrated at one-year post-transplant.

  • Cell Therapy
  • Specialty Hospital
  • Therapy
  • Transplantation
  • Pluristem Therapeutics Inc.
  • BALMES TRANSPLANTATION SAS
  • KIDNEY TRANSPLANT REJECTION - PIPELINE BY BALMES TRANSPLANTATION SAS, H1 2018

Transplant rejection is one of the key challenges of organ transplantation.

  • Healthcare
  • Therapy
  • Transplantation
  • United States
  • Product Initiative

The report focuses on drugs and therapies being evaluated for Lung Transplantation treatment in active clinical development phases including phase ##, phase ##, phase ## and phase ## clinical trials.

  • Clinical Trial
  • Drug Development
  • General Medicine And Specialty Medicine
  • Lung Transplant
  • Transplantation

The report focuses on drugs and therapies being evaluated for Liver Transplantation treatment in active clinical development phases including phase ##, phase ##, phase ## and phase ## clinical trials.

  • Clinical Trial
  • Drug Development
  • General Medicine And Specialty Medicine
  • Liver Transplant
  • Transplantation

The report focuses on drugs and therapies being evaluated for Heart Transplantation treatment in active clinical development phases including phase ##, phase ##, phase ## and phase ## clinical trials.

  • Clinical Trial
  • Drug Development
  • General Medicine And Specialty Medicine
  • Heart Transplant
  • Transplantation